V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010789 | 190005222 | 1.57 | 75 | Curative (C) | null | 2020-02-22 | Doxorubicin 75mg/m2 | null | null | DOXORUBICIN | 101446517 |
| 190010790 | 190005223 | 1.72 | 89 | Palliative (P) | 2020-10-25 | 2020-11-08 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100584547 |
| 190010791 | 190005224 | null | 83.75 | null | 2016-06-28 | 2016-06-28 | CISPLATIN + ETOPOSIDE | null | null | EW EUROEWING 2012 ARM B VDC | 100854769 |
| 190010797 | 190005225 | 1.56 | 75.7 | Palliative (P) | 2019-02-07 | 2019-02-21 | Cyclophosphamide + Topotecan | 02 | null | EW EUROEWING 2012 ARM A VAI | 101477224 |
| 190010798 | 190005226 | 1.75 | 57.9 | Curative (C) | 2016-09-07 | 2016-09-08 | TEMOZOLOMIDE | 02 | N | METHOTREXATE HIGH DOSE | 100833984 |
| 190010800 | 190005227 | 1.65 | 53.6 | Palliative (P) | 2017-04-01 | 2017-04-21 | OST Euramos 1 Closed Trial - IE | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100086834 |
| 190010808 | 190005228 | 1.7 | 72 | null | 2018-04-20 | 2018-04-20 | OST Euramos 1 Closed Trial - M | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101185865 |
| 190010809 | 190005229 | 1.81 | 94.2 | Curative (C) | 2017-02-07 | 2017-04-04 | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | STS RHABDO RMS 2005 2ND TOPO CYCLO | 101652159 |
| 190010810 | 190005230 | 1.84 | 52.2 | Palliative (P) | 2018-04-14 | 2018-04-23 | Cyclophosphamide + Topotecan | 02 | N | DOXORUBICIN + METHOTREXATE | 100170944 |
| 190010819 | 190005231 | 1.79 | 52 | Palliative (P) | 2018-08-01 | 2018-08-01 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CAV | 101493385 |
| 190010833 | 190005232 | 1.69 | 51.9 | Palliative (P) | 2019-10-30 | 2020-04-23 | CARBO + THIOTEPA + TOPOTECAN | 01 | null | ETOPOSIDE | 100527408 |
| 190010834 | 190005233 | 1.6 | 75.5 | Curative (C) | 2016-08-26 | 2017-02-01 | EW EuroEwing 2012 Arm A VAI | 02 | N | IRINOTECAN + TEMOZOLOMIDE | 100099713 |
| 190010837 | 190005234 | 1.81 | 13.2 | Curative (C) | 2018-07-23 | 2018-07-30 | OST Euramos 1 Closed Trial - A | 02 | null | DOXORUBICIN | 101586453 |
| 190010850 | 190005236 | 1.56 | 65 | Curative (C) | 2018-07-26 | 2018-08-19 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100033451 |
| 190010853 | 190005237 | 0.78 | 59.8 | Adjuvant (A) | 2016-11-06 | 2017-04-05 | Paclitaxel 7 day | 02 | null | IFOSFAMIDE | 100377460 |
| 190010854 | 190005238 | 1.59 | null | Curative (C) | 2016-05-31 | 2018-02-02 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100789276 |
| 190010858 | 190005239 | 1.58 | 57.9 | Neo-adjuvant (N) | 2014-10-30 | 2014-11-01 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101419259 |
| 190010859 | 190005240 | 1.14 | 123.4 | null | 2020-09-01 | 2020-09-15 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | IRINOTECAN + TEMOZOLOMIDE | 100146635 |
| 190010862 | 190005241 | 1.69 | 73.65 | 03 | 2019-11-19 | 2019-12-03 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100176446 |
| 190010868 | 190005242 | 1.78 | 82.4 | null | 2016-06-21 | 2016-08-24 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100206002 |
| 190010872 | 190005243 | 1.77 | 83.2 | Curative (C) | 2017-04-07 | 2017-04-22 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101389407 |
| 190010881 | 190005244 | 0 | 72.1 | Neo-adjuvant (N) | 2018-05-20 | 2019-01-24 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101581794 |
| 190010887 | 190005245 | 1.79 | 83.8 | Adjuvant (A) | 2015-09-04 | 2015-10-10 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101753075 |
| 190010888 | 190005246 | 0 | 24 | Curative (C) | 2017-02-16 | 2017-03-23 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101759564 |
| 190010889 | 190005247 | 1.73 | 41 | null | 2021-05-07 | 2021-05-09 | EW Rel rEECur Topotecan/Cyclophosphamide | 01 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101177069 |
| 190010903 | 190005248 | 1.83 | 71.8 | Adjuvant (A) | 2018-05-19 | 2018-09-30 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101580678 |
| 190010905 | 190005249 | 1.77 | 75.2 | Curative (C) | 2017-04-04 | 2017-04-07 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | IMATINIB | 100829799 |
| 190010914 | 190005250 | 1.74 | 34.2 | null | 2017-05-27 | 2017-09-05 | EW EuroEwing 2012 Arm B IE | null | null | EW EUROEWING 2012 ARM B IE | 101520353 |
| 190010918 | 190005251 | 1.6 | 76.3 | Palliative (P) | 2020-01-10 | 2020-01-10 | OST Euramos 1 Closed Trial - Ai | 02 | Y | LIPOSOMAL DOXORUBICIN | 101306097 |
| 190010921 | 190005252 | 1.67 | 59 | Palliative (P) | 2019-03-17 | 2019-03-17 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100443179 |
| 190010926 | 190005253 | 1.71 | 70 | Palliative (P) | 2017-07-01 | 2017-07-28 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | CYCLOPHOSPHAMIDE HIGH DOSE | 101195027 |
| 190010928 | 190005254 | 1.72 | 65.5 | Curative (C) | 2018-01-10 | 2018-01-15 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101391675 |
| 190000680 | 190005256 | 1.63 | 69.4 | Palliative (P) | 2016-05-09 | 2016-09-26 | NB HRNBL-1 COJEC Ind COURSE A | 01 | N | EW EUROEWING 2012 ARM B VDC | 101671483 |
| 190000808 | 190005257 | 1.56 | 20.3 | Curative (C) | 2019-12-05 | 2019-12-07 | Paclitaxel 7 day | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101186648 |
| 190002742 | 190005258 | 1.7 | 104.8 | Curative (C) | 2019-05-25 | 2019-07-07 | ETOPOSIDE + IFOSFAMIDE | 01 | N | ETOPOSIDE + IFOSFAMIDE | 100678585 |
| 190003001 | 190005259 | 1.61 | 63.5 | Curative (C) | 2019-01-31 | 2019-02-04 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101520261 |
| 190003454 | 190005260 | 0 | 46 | Palliative (P) | 2018-05-07 | 2018-05-31 | Trastuzumab | 02 | N | EURO-EWING | 100230226 |
| 190003789 | 190005261 | 0 | 38.4 | null | 2018-05-20 | 2018-06-24 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 101294712 |
| 190003862 | 190005262 | 0 | 4.5 | Neo-adjuvant (N) | 2019-11-08 | 2019-11-12 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100394493 |
| 190004140 | 190005263 | 1.79 | 54.4 | Palliative (P) | 2019-01-05 | 2019-01-19 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101394150 |
| 190004163 | 190005264 | 0 | 23.3 | Neo-adjuvant (N) | 2017-02-18 | 2017-03-02 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101625605 |
| 190004507 | 190005265 | 0 | 38.9 | Neo-adjuvant (N) | 2016-08-31 | 2016-11-09 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100253445 |
| 190004898 | 190005267 | 1.63 | 57 | Curative (C) | 2017-04-04 | 2017-04-05 | null | 01 | N | LIPOSOMAL DOXORUBICIN | 101814779 |
| 190004933 | 190005268 | 1.82 | 68.9 | Palliative (P) | 2018-12-28 | 2019-03-16 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100493281 |
| 190004955 | 190005269 | 1.87 | null | Palliative (P) | 2019-03-13 | 2019-11-24 | EC | N | N | TRABECTEDIN | 101823843 |
| 190005229 | 190005270 | null | 64.8 | null | 2021-04-20 | 2021-04-20 | Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101462661 |
| 190005471 | 190005271 | 1.8 | 72.2 | Neo-adjuvant (N) | 2019-06-24 | 2020-01-02 | CAV | 02 | null | EURO-EWING | 100817180 |
| 190005536 | 190005272 | 1.68 | 79.2 | Curative (C) | 2018-05-04 | 2018-08-19 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100026062 |
| 190005990 | 190005273 | 1.66 | 48.8 | 03 | 2017-09-11 | 2018-02-17 | PAM x 2 post-surgery (cycles 3&4) | 2 | null | ETOPOSIDE | 100280697 |
| 190006089 | 190005274 | null | 62.1 | Curative (C) | 2017-02-28 | 2017-11-14 | MAP | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100145043 |